(Q45842681)

16 December 2017

title

Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection (English)

1 reference

16 December 2017

0 references

Yanagisawa M

1

1 reference

16 December 2017

Kato M

2

1 reference

16 December 2017

Ikeno K

3

1 reference

16 December 2017

Kobayashi T

4

1 reference

16 December 2017

Miyagawa Y

5

1 reference

16 December 2017

Komiyama A

6

1 reference

16 December 2017

Akabane T

7

1 reference

16 December 2017

publication date

1 May 1987

1 reference

16 December 2017

Clinical and Experimental Immunology

published in

1 reference

16 December 2017

volume

68

1 reference

16 December 2017

issue

2

1 reference

16 December 2017

page(s)

251-258

1 reference

16 December 2017

Fatal infectious mononucleosis in a family

cites work

1 reference

12 December 2020

X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)

1 reference

12 December 2020

Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice

1 reference

12 December 2020

Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis

1 reference

12 December 2020

Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate

1 reference

12 December 2020

Fatal epstein-barr virus-associated hemophagocytic syndrome

1 reference

12 December 2020

Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens

1 reference

12 December 2020

Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations

1 reference

12 December 2020

Childhood lymphoblastic leukemia with natural killer activity: establishment of the leukemia cell lines retaining the activity.

1 reference

12 December 2020

The mechanism of inhibition of human IL 2 production

1 reference

12 December 2020

Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects

1 reference

12 December 2020

Analysis of cellular immune response to EBV by using cloned T cell lines

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

12 December 2020

X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency

1 reference

12 December 2020

Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens

1 reference

12 December 2020

Fatal Epstein-Barr-Virus-Associated Proliferation of Donor B Cells After Treatment of Acute Graft-Versus-Host Disease with a Murine Anti-T-Cell Antibody

1 reference

12 December 2020

Paired epstein-barr virus-carrying lymphoma and lymphoblastoid cell lines Burkitt's lymphoma patients: Comparative sensitivity to non-specific and to allo-specific cytotoxic responsesin vitro

1 reference

12 December 2020

Human alloreactive CTL clones: loss and reacquisition of specific cytolytic activity can be regulated by "recombinant" interleukin 2.

1 reference

12 December 2020

Immune function in chronic active Epstein-Barr virus infection

1 reference

12 December 2020

Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies.

1 reference

12 December 2020

Epstein-Barr virus infection and immunoregulation in man.

1 reference

12 December 2020

T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines

1 reference

12 December 2020

Interaction of interleukin 2 with cells: quantitative analysis of effects

1 reference

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

12 December 2020

Induction of alloreactive cytotoxic T cells by acute virus infection of mice.

1 reference

12 December 2020

Production of T cell differentiation factor in syngeneic lymphocyte macrophage culture for cytotoxic T lymphocyte generation

1 reference

12 December 2020

A family study of the X-linked lymphoproliferative syndrome: evidence for a B cell defect contributing to the immunodeficiency.

1 reference

12 December 2020

Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity.

1 reference

12 December 2020

Identifiers

1 reference

16 December 2017